What does a 13 mm raised reaction to the Mantoux (Tuberculin) test indicate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 3, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Interpretation of a 13 mm Mantoux Test Result

A 13 mm raised induration on the Mantoux tuberculin skin test is positive and indicates tuberculosis infection in most individuals, requiring further evaluation with chest radiography and consideration for treatment of latent TB infection. 1

Risk-Stratified Interpretation Framework

The interpretation of your 13 mm induration depends on your specific risk category, as the American Thoracic Society/CDC guidelines use three distinct cutoff thresholds 1:

Positive at ≥5 mm (Highest Risk Groups)

Your 13 mm result is definitively positive if you fall into any of these categories 1, 2:

  • HIV-positive persons (regardless of symptoms) 1
  • Recent close contacts of someone with active pulmonary TB 1
  • Immunosuppressed patients, including those on TNF-blocking agents or high-dose corticosteroids (≥15 mg/day prednisone for ≥1 month) 1, 3
  • Persons with fibrotic changes on chest X-ray consistent with prior TB 1, 2
  • Organ transplant recipients 1, 3

Positive at ≥10 mm (Moderate Risk Groups)

Your 13 mm result is positive if you belong to these categories 1, 2:

  • Foreign-born persons from high TB prevalence countries (Asia, Africa, Latin America) who arrived within the last 5 years 1, 3
  • Injection drug users 1, 3
  • Healthcare workers with occupational TB exposure risk 3, 4
  • Residents or employees of high-risk congregate settings (prisons, homeless shelters, nursing homes) 1, 3
  • Persons with medical conditions that increase TB risk: diabetes mellitus, chronic renal failure, silicosis, gastrectomy, weight loss >10% ideal body weight 1, 3
  • Children <4 years old or those exposed to high-risk adults 2, 3

Positive at ≥15 mm (Low Risk/No Risk Factors)

Your 13 mm result would be negative only if you have absolutely no risk factors for TB exposure or progression 1, 2. However, this scenario is uncommon in clinical practice, as most individuals undergoing Mantoux testing have some identifiable risk factor 1.

Critical Considerations That May Affect Interpretation

BCG Vaccination Status

  • BCG vaccination does not change the interpretation of your positive result, particularly if you were vaccinated in infancy or more than 10 years ago 1, 2
  • BCG-induced tuberculin reactivity typically wanes over time and is unlikely to persist beyond 10 years 2
  • A positive TST in BCG-vaccinated persons should still be considered indicative of TB infection, especially in those from high-prevalence countries 2
  • The size of induration does not reliably distinguish between M. tuberculosis infection and prior BCG vaccination 2
  • If BCG vaccination is causing diagnostic uncertainty, consider IGRA testing (QuantiFERON or T-SPOT) as these tests are not affected by BCG 3, 5

False-Positive Considerations

Your 13 mm result could potentially be a false-positive if 1:

  • You have infection with nontuberculous mycobacteria (environmental mycobacteria) 1
  • You received BCG vaccination, particularly if given after infancy or as repeat vaccination 1

False-Negative Risk Factors (Not Applicable to Your Positive Result)

While your test is positive, be aware that false-negative results can occur in 1:

  • Early infection (<6-8 weeks after exposure) 1
  • Severe immunosuppression (HIV with low CD4 count, overwhelming TB disease) 1
  • Recent live viral vaccination (measles, mumps, rubella) within 4-6 weeks 1
  • Infants and young children 1

Mandatory Next Steps

Immediate Evaluation Required

All persons with a positive TST must undergo chest radiography to rule out active TB disease before any treatment for latent TB infection is initiated 1, 3, 6. This is non-negotiable. 3

Symptom Assessment

You must be evaluated for TB symptoms including 3:

  • Cough (especially >2-3 weeks duration) 6
  • Hemoptysis (coughing up blood)
  • Fever and night sweats
  • Unintentional weight loss
  • Chest pain
  • Shortness of breath
  • Fatigue

If any symptoms are present, you require immediate evaluation for active TB disease with sputum samples for acid-fast bacilli smear and culture 3, 6.

Treatment Considerations

If chest X-ray is normal and you have no symptoms of active TB 1:

  • Treatment of latent TB infection is strongly recommended to prevent progression to active disease 1
  • Standard regimen: 9 months of isoniazid (preferred for most patients) 1
  • Alternative: 2 months of rifampin plus pyrazinamide or 4 months of rifampin alone 1
  • For children, isoniazid for 9 months is the only recommended regimen 1

Common Pitfalls to Avoid

  • Do not measure erythema (redness) alone—only palpable induration counts 1, 2
  • Do not ignore a positive result in BCG-vaccinated individuals—treat it as indicating TB infection 2, 3
  • Do not use a negative TST to exclude active TB disease, especially in immunosuppressed patients 1
  • Do not initiate latent TB treatment without first obtaining a chest X-ray 3, 6
  • Do not test unless prepared to treat—testing should only be done when there is a plan to complete treatment if positive 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Understanding Induration in Tuberculin Skin Testing

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Tuberculosis Diagnostic Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Factors associated with positive Mantoux results in NHS healthcare workers.

Occupational medicine (Oxford, England), 2018

Research

Comparison of tuberculin skin test and new specific blood test in tuberculosis contacts.

American journal of respiratory and critical care medicine, 2004

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.